IRIS UniCatt

Bottoni, Patrizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.235
AS - Asia 1.570
EU - Europa 1.411
SA - Sud America 280
AF - Africa 34
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.536
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.172
SG - Singapore 634
CN - Cina 462
DE - Germania 414
BR - Brasile 214
UA - Ucraina 205
SE - Svezia 203
VN - Vietnam 128
FR - Francia 118
IT - Italia 108
GB - Regno Unito 77
IE - Irlanda 72
IN - India 66
FI - Finlandia 59
TR - Turchia 54
ID - Indonesia 49
RU - Federazione Russa 48
CA - Canada 39
JP - Giappone 32
BD - Bangladesh 31
HK - Hong Kong 26
AR - Argentina 23
BE - Belgio 16
IQ - Iraq 16
KR - Corea 16
NL - Olanda 16
ES - Italia 15
MX - Messico 10
VE - Venezuela 10
PK - Pakistan 9
ZA - Sudafrica 9
CH - Svizzera 8
PL - Polonia 7
SA - Arabia Saudita 7
CL - Cile 6
CZ - Repubblica Ceca 6
EC - Ecuador 6
MA - Marocco 6
MY - Malesia 6
RO - Romania 6
AT - Austria 5
CO - Colombia 5
PY - Paraguay 5
BO - Bolivia 4
DZ - Algeria 4
IL - Israele 4
IR - Iran 4
KE - Kenya 4
PT - Portogallo 4
UY - Uruguay 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AU - Australia 3
DK - Danimarca 3
EG - Egitto 3
HN - Honduras 3
NO - Norvegia 3
PE - Perù 3
AZ - Azerbaigian 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
HU - Ungheria 2
JM - Giamaica 2
KZ - Kazakistan 2
LT - Lituania 2
LU - Lussemburgo 2
NG - Nigeria 2
PH - Filippine 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
ME - Montenegro 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 5.535
Salva come PNG Salva come JPEG
Città #
Singapore 337
Chandler 294
Ashburn 245
San Jose 184
Jacksonville 103
Beijing 81
San Mateo 76
New York 74
Nanjing 72
Dublin 68
The Dalles 53
Wilmington 48
Ann Arbor 46
Hefei 43
Redmond 43
Izmir 42
Los Angeles 41
Jakarta 40
Woodbridge 40
Lauterbourg 38
Dearborn 37
Hanoi 37
Houston 37
Ho Chi Minh City 36
Boston 31
Chicago 31
Lawrence 30
Bremen 24
Hong Kong 24
Moscow 23
Tokyo 23
Frankfurt am Main 22
Cattolica 21
São Paulo 21
Fairfield 20
Seattle 20
Detroit 18
Boardman 17
Kent 16
Kunming 16
Montreal 15
Mountain View 15
Nanchang 15
Helsinki 14
Nürnberg 14
Shanghai 14
Zhengzhou 14
Redwood City 13
Brussels 12
London 12
Munich 12
Hangzhou 11
Hebei 11
Philadelphia 11
Rome 11
Seoul 11
Brooklyn 10
Pune 10
Santa Clara 10
Shenyang 10
Princeton 9
Toronto 9
Belo Horizonte 8
Guangzhou 8
Milan 8
Orem 8
University Park 8
Atlanta 7
Buffalo 7
Cambridge 7
Dhaka 7
Düsseldorf 7
Lancaster 7
Paris 7
Chengdu 6
Dallas 6
Edinburgh 6
Madrid 6
Memphis 6
Tianjin 6
Turku 6
Baghdad 5
Cardiff 5
Da Nang 5
Haiphong 5
Indiana 5
Jiaxing 5
Johannesburg 5
Portsmouth 5
Simi Valley 5
Zurich 5
Biên Hòa 4
Brasília 4
Changsha 4
Curitiba 4
Goiânia 4
Lansing 4
Lanzhou 4
Littleton 4
Marseille 4
Totale 2.952
Salva come PNG Salva come JPEG
Nome #
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects 207
CA 19-9: Biochemical and Clinical Aspects 200
MITOCHONDRIAL DAMAGE AND METABOLIC COMPENSATORY MECHANISMS INDUCED BY HYPEROXIA IN U-937 CELL LINE. 189
A proteomic approach to characterizing ciglitazone-induced cancer cell differentiation in Hep-G2 cell line 189
Neuron Specific Enolase as a biomarker: biochemical and clinical aspects 187
3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 3. Discovery of Novel Lead Compounds Through Structure-Based Drug Design and Docking Studies 186
Mitochondria, ciglitazone and liver: a neglected interaction in biochemical pharmacology. 176
Mitochondrial proteomic approaches for new potential diagnostic and prognostic biomarkers in cancer 176
Advances in Mitochondrial Medicine 165
A two-dimensional electrophoresis preliminary approach to human hepatocarcinoma differentiation induced by PPAR-agonists. 163
An update on pharmacological approaches to neurodegenerative diseases. 161
A Critical Approach to Clinical Biochemistry of Chromogranin A 161
The Role of CA 125 as Tumor Marker: Biochemical and Clinical Aspects 158
Circulating tumour cells and cancer stem cells: A role for proteomics in defining the interrelationships between function,phenotype and differentiation with potential clinical applications. 156
The epithelial–mesenchymal transition in cancer: a potential critical topic for translational proteomic research 155
3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 2. Effect of Pyrrole C2 and/or C4 Substitutions on Biological Activity 153
Bezafibrate Induces a Mitochondrial Derangement in Human Cell Lines. Intriguing Effects for a Peroxisome Proliferator. 152
CA 19-9: Biochemical and Clinical Aspects 150
Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy 147
The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. 143
The proteomics of cancer stem cells. Potential clinical applications for innovative research in oncology 136
Cancer stem cells: the development of new cancer therapeutics 133
Cancer Stem Cells: An Innovative Therapeutic Approach 132
Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential. 132
Modulation of cancer cell line differentiation: A neglected proteomic analysis with potential implications in pathophysiology, diagnosis, prognosis, and therapy of cancer. 131
CA 19-9: Biochemical and Clinical Aspects 129
Proteomic profiling of heat shock proteins: An emerging molecular approach with direct pathophysiological and clinical implications 127
Pharmacological modulation of nitric oxide release: new pharmacological perspectives, potential benefits and risks. 126
The role of CA 125 as tumor marker: biochemical and clinical aspects 124
A critical approach to clinical biochemistry of Chromogranin A 124
Cancer Stem Cells: Proteomic Approaches for New Potential Diagnostic and Prognostic Biomarkers 121
Advances in Heat Shock Proteomics: Towards a Better Understanding of the Physiology and Pathophysiology of Molecular Chaperones. 120
Glycolytic enzyme inhibitors in cancer treatment. 110
Exploring the connection unit in the HDAC inhibitor pharmacophore model: novel uracil-based hydroxamates. 101
Mitochondrial respiration and differentiation 100
Aroyl-Pyrrolyl Hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetilase inhibition 97
Cellular respiration and dedifferentiation 93
Aroyl-pyrrolyl hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetylase inhibition. 82
Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key? 81
Totale 5.573
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.627
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022343 29 39 4 39 21 16 8 56 8 17 37 69
2022/2023792 100 107 60 124 78 91 13 77 81 20 33 8
2023/2024319 19 95 4 7 12 62 13 13 4 13 45 32
2024/2025729 22 17 51 26 70 25 19 50 99 86 128 136
2025/20261.772 270 56 108 175 269 125 360 108 128 99 42 32
2026/202747 47 0 0 0 0 0 0 0 0 0 0 0
Totale 5.573